Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

被引:24
|
作者
Artykov, Artem A. [1 ]
Yagolovich, Anne, V [1 ,2 ]
Dolgikh, Dmitry A. [1 ,2 ]
Kirpichnikov, Mikhail P. [1 ,2 ]
Trushina, Daria B. [3 ]
Gasparian, Marine E. [1 ]
机构
[1] RAS, Dept Bioengn, Inst Bioorgan Chem, Moscow, Russia
[2] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia
[3] Russian Acad Sci, Dept Xray & Synchrotron Res, AV Shubnikov Inst Crystallog Fed Sci Res Ctr Crys, Moscow, Russia
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
基金
俄罗斯基础研究基金会; 俄罗斯科学基金会;
关键词
DR5; DR4; TRAIL; receptor endocytosis; receptor recycling; membrane traffic; brefeldin A; SURFACE EXPRESSION; APOPTOSIS; RESISTANCE; CLATHRIN; NUCLEAR; INTERNALIZATION; LOCALIZATION; TRAFFICKING; APO2L/TRAIL; SELECTIVITY;
D O I
10.3389/fcell.2021.733688
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor necrosis factor-associated ligand inducing apoptosis (TRAIL) induces apoptosis through the death receptors (DRs) 4 and 5 expressed on the cell surface. Upon ligand stimulation, death receptors are rapidly internalized through clathrin-dependent and -independent mechanisms. However, there have been conflicting data on the role of death receptor endocytosis in apoptotic TRAIL signaling and possible cell type-specific differences in TRAIL signaling have been proposed. Here we have compared the kinetics of TRAIL-mediated internalization and subsequent recycling of DR4 and DR5 in resistant (HT-29 and A549) and sensitive (HCT116 and Jurkat) tumor cell lines of various origin. TRAIL stimulated the internalization of both receptors in a concentration-dependent manner with similar kinetics in sensitive and resistant cell lines without affecting the steady-state expression of DR4 and DR5 in cell lysates. Using the receptor-selective TRAIL variant DR5-B, we have shown that DR5 is internalized independently of DR4 receptor. After internalization and elimination of TRAIL from culture medium, the receptors slowly return to the plasma membrane. Within 4 h in resistant or 6 h in sensitive cells, the surface expression of receptors was completely restored. Recovery of receptors occurred both from newly synthesized molecules or from trans-Golgi network, as cycloheximide and brefeldin A inhibited this process. These agents also suppressed the expression of cell surface receptors in a time- and concentration-dependent manner, indicating that DRs undergo constitutive endocytosis. Inhibition of receptor endocytosis by sucrose led to sensitization of resistant cells to TRAIL and to an increase in its cytotoxic activity against sensitive cells. Our results confirm the universal nature of TRAIL-induced death receptor endocytosis, thus cell sensitivity to TRAIL can be associated with post-endocytic events.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer
    Kim, Se-Lim
    Min, In Suk
    Park, Young Ran
    Lee, Soo Teik
    Kim, Sang-Wook
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (06) : 2789 - 2799
  • [42] Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
    Ko, Hyeonseok
    Jeong, Mi-Hyeon
    Jeon, Hyelin
    Sung, Gi-Jun
    So, Youngsin
    Kim, Inki
    Son, JaeKyoung
    Lee, Sang-wook
    Yoon, Ho-Geun
    Choi, Kyung-Chul
    ONCOTARGET, 2015, 6 (12) : 9970 - 9984
  • [43] TRAIL enhances quinacrine-mediated apoptosis in breast cancer cells through induction of autophagy via modulation of p21 and DR5 interactions
    Das, Sarita
    Nayak, Anmada
    Siddharth, Sumit
    Nayak, Deepika
    Narayan, Satya
    Kundu, Chanakya Nath
    CELLULAR ONCOLOGY, 2017, 40 (06) : 593 - 607
  • [44] Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo
    Qiao, Xinran
    Wang, Xiaofei
    Shang, Yue
    Li, Yi
    Chen, Shu-zhen
    CANCER COMMUNICATIONS, 2018, 38
  • [45] Lipocalin 2 negatively regulates TRAIL sensitivity through p38-mediated DR5 regulation in human colorectal cancer
    Yang, Hee Chan
    Kim, Se Lim
    Kim, In Hee
    Lee, Seung Ok
    Lee, Soo Teik
    Kim, Sang Wook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 448 - 448
  • [46] Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and death receptor (DR4) genes contribute to susceptibility to colorectal cancer in pakistani population
    Zahoor, A.
    Mansoor, Q.
    Farooqi, A. A.
    Fayyaz, S.
    Naz, G.
    Ismail, M.
    CELLULAR AND MOLECULAR BIOLOGY, 2015, 61 (06) : 108 - 112
  • [47] MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation
    Lim, Sung-Chul
    Hanz, Song Ly
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2017, 21 (04) : 397 - 405
  • [48] FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells
    Woo, Seon Min
    Seo, Bo Ram
    Min, Kyoung-jin
    Kwon, Taeg Kyu
    ONCOTARGET, 2015, 6 (13) : 11614 - 11626
  • [49] Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively
    Kajiwara, K
    Saito, A
    Ogata, S
    Tanihara, M
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1699 (1-2): : 131 - 137
  • [50] Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells
    Park, Eun Jung
    Min, Kyoung-jin
    Choi, Kyeong Sook
    Kubatka, Peter
    Kruzliak, Peter
    Kim, Dong Eun
    Kwon, Taeg Kyu
    SCIENTIFIC REPORTS, 2016, 6